Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

San Ramon, California Clinical Trials

A listing of San Ramon, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (5) clinical trials

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 diabetes. Participants will get semaglutide (active medicine) or placebo ('dummy medicine'). This is known as participants' study medicine - which treatment participants get is ...

Phase

2.16 miles

Learn More »

Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds

The study will be conducted in an outpatient setting of an academic clinical center over a total period of four weeks (28 days, -1/+2). The aim of this RCT is to evaluate and compare three different foam dressings in the local management of chronic wounds (i.e. venous leg ulcers (VLUs) ...

Phase N/A

7.7 miles

Learn More »

EMS for Abdominal and Gluteal Muscle Toning

Evaluate the use of Electromagnetic Muscle Stimulation for body contouring.

Phase N/A

7.82 miles

Learn More »

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Primary Objective of the Master Protocol (LUNGMAP) The primary objective of this screening study is to test patient specimens to determine eligibility for participation in the biomarker-driven and non-matched sub-studies included within the Lung-MAP umbrella protocol. Secondary Objectives Screening Success Rate Objective To evaluate the screen success rate defined as ...

Phase

9.62 miles

Learn More »

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

This study compares the effect of two doses of semaglutide (1.0 mg and 2.0 mg) in people with type 2 diabetes (T2D). People taking part in the study will take the medicine together with their current diabetes medicine (sulphonylurea and/or metformin). Participants will get a dose of either 1.0 mg ...

Phase

9.98 miles

Learn More »